What is Babyscripts?
Babyscripts was founded with the explicit goal of revolutionizing maternity care delivery by leveraging advanced technology. The company's platform integrates a mobile application with remote patient monitoring and comprehensive care management services. By targeting key drivers of the maternal health crisis, Babyscripts aims to improve pregnancy outcomes and ultimately eliminate preventable maternal mortality. Their approach emphasizes providing data-driven care to a broader population, thereby enhancing access and addressing disparities in healthcare.
How much funding has Babyscripts raised?
Babyscripts has raised a total of $41M across 6 funding rounds:
Other Financing Round
$900K
Other Financing Round
$1M
Private Equity
$7.9M
Series A
$5.7M
Other Financing Round
$6M
Series B
$19.5M
Other Financing Round (2013): $900K with participation from Kensington Partners and Ense Group
Other Financing Round (2015): $1M led by Kensington Capital Partners Limited
Private Equity (2016): $7.9M, investors not publicly disclosed
Series A (2017): $5.7M featuring Ysios Capital, Chemo Group, P5 Health Ventures, and CG Health Ventures
Other Financing Round (2019): $6M backed by Philips, StartUp Health, and NueCura Partners
Series B (2021): $19.5M with participation from Atlantic Health System, Cigna Ventures, CU Healthcare Innovation Fund, MemorialCare Innovation Fund, Philip Ventures, and Texas Medical Center
Key Investors in Babyscripts
Atlantic Health System
Atlantic Health System is a leading non-profit healthcare system recognized for setting high standards in medical care across the region, providing comprehensive healthcare services through multiple acute care hospitals and specialized institutes.
Cigna Ventures
Cigna Ventures is a venture capital fund focused on investments that accelerate Cigna's strategic mission of improving customers' health, well-being, and sense of security.
Ysios Capital
Ysios Capital is a leading life sciences venture capital firm that invests in highly innovative biotechnology companies worldwide, providing resources to develop novel therapies for significant unmet medical needs.
What's next for Babyscripts?
The recent major strategic investment signals a pivotal growth phase for Babyscripts. This capital infusion is anticipated to fuel further development of their technological solutions and expand their market reach. Strategic partnerships and continued innovation in remote patient monitoring and care management are likely to be key priorities. Babyscripts is poised to further solidify its role in improving maternal health outcomes by scaling its operations and enhancing its data-driven approach to care delivery, potentially leading to broader adoption across healthcare systems.
See full Babyscripts company page
